Average Co-Inventor Count = 11.88
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (16 from 822 patents)
2. Abbott Laboratories Corporation (6 from 4,177 patents)
3. The Walter and Eliza Hall Institute of Medical Research (3 from 80 patents)
4. Genentech, Inc. (2 from 3,221 patents)
5. Abbvie Bahamas Limited (6 patents)
22 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
3. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
4. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
5. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
6. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
7. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
8. 9072748 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
9. 9045420 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10. 9029404 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11. 8952157 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12. 8586754 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
13. 8563735 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
14. 8557983 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
15. 8546399 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases